Nasopharyngeal carcinoma: Advances in genomics and molecular genetics

Science China Life Sciences

Volumn 54, Issue 10, 2011, Pages 966-975

  Zeng, Zhao Yang ^a   Huang, Hong Bin ^a   Zhang, Wen Ling ^a   Xiang, Bo ^a   Zhou, Ming ^a   Zhou, Yan Hong ^a   Ma, Jian ^a   Yi, Mei ^a,b   Li, Xia Yu ^a   Li, Xiao Ling ^a   Xiong, Wei ^a   Li, Gui Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ARTICLE; CELL TRANSFORMATION; EPSTEIN BARR VIRUS; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETICS; GENOMICS; HUMAN; MICROBIOLOGY; NASOPHARYNX TUMOR; PATHOGENICITY; PROTEOMICS; RISK FACTOR; VIROLOGY;

CELL TRANSFORMATION, NEOPLASTIC; EPIGENESIS, GENETIC; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTEOMICS; RISK FACTORS; TRANSCRIPTOME;

EID: 80155151745     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-011-4223-5     Document Type: Article

References (182)

1. Lo K W, To K F, Huang D P. Focus on nasopharyngeal carcinoma. Cancer Cell, 2004, 5: 423-428.
2. Wei W I, Sham J S T. Nasopharyngeal carcinoma. Lancet, 2005, 365: 2041-2054.
3. Friborg J, Wohlfahrt J, Koch A, et al. Cancer susceptibility in nasopharyngeal carcinoma families-a population-based cohort study. Cancer Res, 2005, 65: 8567-8572.
4. Chien Y C, Chen J Y, Liu M Y, et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med, 2001, 345: 1877-1882.
5. Lin J C, Wang W Y, Chen K Y, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med, 2004, 350: 2461-2470.
6. Li G Y, Liu H Y, Zhou M, et al. The molecular mechanism involved in the development of nasopharyngeal carcinoma. Prog Biochem Biophys, 2006, 33: 922-931.
7. Hildesheim A, Apple R J, Chen C J, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst, 2002, 94: 1780-1789.
8. Lu S J, Day N E, Degos L, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature, 1990, 346: 470-471.
9. Xiong W, Zeng Z Y, Xia J H, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res, 2004, 64: 1972-1974.
10. Zeng Z Y, Zhou Y H, Zhang W L, et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med, 2006, 8: 156-160.
11. Feng B J, Huang W, Shugart Y Y, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet, 2002, 31: 395-399.
12. Hu L F, Qiu Q H, Fu S M, et al. A genome-wide scan suggests a susceptibility locus on 5p13 for nasopharyngeal carcinoma. Eur J Hum Genet, 2008, 16: 343-349.
13. Zhou G Q, Zhai Y, Cui Y, et al. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res 2007, 13: 2627-2633.
14. Xiong W, Zeng Z Y, Shen S R, et al. Studies of single nucleotide polymorphisms in UBAP1 gene and their association with nasopharyngeal carcinoma. Prog Biochem Biophys, 2002, 29: 766-770.
15. Xiong W, Zeng Z Y, Xiao B Y, et al. Studies of association between nasopharyngeal carcinoma and single-nucleotide polymorphisms in NOR1, a novel oxidored-nitro domain-containing protein gene. Prog Biochem Biophys, 2003, 30: 401-405.
16. Yu Y, Zhu S G, Xiang J J, et al. Coding-region single nucleotide polymorphisms in BRD7 gene and nasopharyngeal carcinoma susceptibility. Prog Biochem Biophys, 2001, 28: 568-572.
17. Zeng Z Y, Xiong W, Shen S R, et al. High-throughput single nucleotide polymorphisms genotyping by dynamic allele-specific hybridization. Prog Biochem Biophys, 2002, 29: 806-810.
18. Jia W H, Pan Q H, Qin H D, et al. A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis, 2009, 30: 2031-2036.
19. He Y, Zhou G, Zhai Y, et al. Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J Med Genet, 2005, 42: 172-176.
20. Xiong W, Zeng Z Y, Li X L, et al. Single-nucleotide polymorphisms in NGX6 gene and their correlation with nasopharyngeal carcinoma. Acta Biochim Et Biophys Sin, 2002, 34: 512-515.
21. Sun Y L, Liu F, Zhao X H. Genome-wide association analysis based on copy number variations. Prog Biochem Biophys, 2009, 36: 968-977.
22. Tse K P, Su W H, Chang K P, et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21. 3. Am J Hum Genet, 2009, 85: 194-203.
23. Ng C C, Yew P Y, Puah S M, et al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet, 2009, 54: 392-397.
24. Bei J X, Li Y, Jia W H, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet, 2010, 42: 599-U173.
25. Zhang B C, Cao L, Qian J, et al. Construction of directional cDNA library from human embryo nasopharyngeal epithelia and screening a candidate tumor suppressor gene related with nasopharyngeal carcinoma. Prog Biochem Biophys, 2002, 29: 302-306.
26. Zhang B C, Nie X M, Xiao B Y, et al. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Gene Chromosomes Canc, 2003, 38: 80-90.
27. Zhang B C, Zhou M, Zhou H D, et al. Characterization analysis of nasopharyngeal carcinoma differentially expressed gene PROL4. Prog Biochem Biophys, 2003, 30: 262-265.
28. Zhou Y H, Zeng Z Y, Zhang W L, et al. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization. Eur J Cancer Prev, 2008, 17: 561-571.
29. Huang C, Wu M H, Li G Y. The present and advance in transcriptomics of nasopharyngeal carcinoma. Prog Biochem Biophys, 2007, 34: 1129-1135.
30. Wang X, Wang X W, Wang L K, et al. A review on the processing and analysis of next-generation RNA-seq data. Prog Biochem Bio phys, 2010, 37: 834-846.
31. Zhou Y H, Zeng Z Y, Xiong W, et al. Microdissection and RNA line-amplification of nasopharyngeal carcinoma tissue. Prog Biochem Biophys, 2005, 32: 463-467.
32. Zeng Z Y, Zhou Y H, Xiong W, et al. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol, 2007, 133: 71-81.
33. Zeng Z Y, Zhou Y H, Zhang W L, et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol, 2007, 38: 120-133.
34. Zhou Y H, Zhang B C, Zeng Z Y, et al. Screening the differential expression genes of nasopharyngeal carcinoma using GenMAPP. Prog Biochem Biophys, 2005, 32: 1121-1129.
35. Zhang W L, Zeng Z Y, Zhou Y H, et al. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Et Biophys Sin, 2009, 41: 414-428.
36. Sriuranpong V, Mutirangura A, Gillespie J W, et al. Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res, 2004, 10: 4944-4958.
37. Sengupta S, den Boon J A, Chen I H, et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res, 2006, 66: 7999-8006.
38. Wang S A, Li X, Li Z G, et al. Gene expression profile changes and possible molecular subtypes in differentiated-type nonkeratinizing nasopharyngeal carcinoma. Int J Cancer, 2011, 128: 753-762.
39. Fan S Q, Xiao B Y, Cao L, et al. A new method to construct the cell microarrays and its application. Prog Biochem Biophys, 2004, 31: 756-760.
40. Fan S Q, Zhang W L, Xiong W, et al. One novel tool and new methods to punch the graft tissues and make the receptive blocks for constructing the tissue microarrays. Prog Biochem Biophys, 2005, 32: 474-479.
41. Hwang B, Li W T, Li W, et al. p-SAGE: Parametric statistical analysis of gene sets. Prog Biochem Biophys, 2009, 36: 1415-1422.
42. Zhang W L, Zhou Y H, Xiao L, et al. Biomarkers of nasopharyngeal carcinoma. Prog Biochem Biophys, 2008, 35: 7-13.
43. Ye H, Liu W, Yu C H, et al. Recent progress of proteomics in nonalcoholic fatty liver disease. Prog Biochem Biophys, 2011, 38: 487-498.
44. Zhu Y M, Xu Q, Dong L R, et al. Identification of proteins associated with let-7a in gastric carcinoma cell line SGC-7901 by proteomics. Prog Biochem Biophys, 2011, 38: 441-448.
45. Li F, Guan Y, Chen Z. Proteomics in nasopharyngeal carcinoma. Cell Mol Life Sci, 2008, 65: 1007-1012.
46. Zhang C F, Tan T, Li J G, et al. Effect of fresh frozen plasma on endothelial cell migration diminishes during storage and its molecular mechanisms. Prog Biochem Biophys, 2011, 38: 528-535.
47. Zhang R, Liu H H, Zhao H X, et al. Comparison of two protein extraction methods for proteomic analysis of chlorophyll-deficient mutants in Brassica juncea L. Prog Biochem Biophys, 2010, 37: 1025-1032.
48. Sun H C, Zhang J Y, Liu H, et al. Algorithm development of de novo peptide sequencing via tandem mass spectrometry. Prog Biochem Biophys, 2010, 37: 1278-1288.
49. Zhang Z Q, Li M Y, Zhang G Y, et al. Quantitative proteome analysis of clinical gastric adenocarcinoma using O-18 stable isotype labeling and LCM. Prog Biochem Biophys, 2009, 36: 311-322.
50. He Z G, Zhong H, Li Q H, et al. Research on the proteome response of Acidithiobacillus ferrooxidans to phosphate starvation by SELDI-Protein Chip technologies. Prog Biochem Biophys, 2008, 35: 77-84.
51. Chen L N, Wang Q, Shang Y K, et al. Human protein structural interaction network: Domain effects on network topology and protein function. Prog Biochem Biophys, 2010, 37: 517-526.
52. Zhang W, Zhang J Y, Liu H, et al. Development of algorithms for mass spectrometry-based label-free quantitative proteomics. Prog Biochem Biophys, 2011, 38: 506-518.
53. Li M X, Xiao Z Q, Peng F, et al. Quantitative proteomics analysis of lcm purified stroma of nasopharyngeal carcinoma and normal nasopharyngeal mucosa. Prog Biochem Biophys, 2009, 36: 1122-1133.
54. Mi W, Wang J. Development of protein quantification based on ICP-MS. Prog Biochem Biophys, 2010, 37: 224-229.
55. Liu Y F, Xiao Z Q, Zhang P F, et al. Quantitative proteomic analysis of metastasis-associated proteins in human primary lung adenocarcinoma. Prog Biochem Biophys, 2009, 36: 448-457.
56. Ouyang Y M. The birth, development and applications of domain-domain interaction databases. Prog Biochem Biophys, 2009, 36: 280-287.
57. Liu Z Y, Li D, Zhu Y P, et al. Progress in the evolutionary analysis of protein interaction networks. Prog Biochem Biophys, 2009, 36: 13-24.
58. Wei X L. Construction and analysis for molecular interaction network of cell adhesion. Prog Biochem Biophys, 2011, 38: 347-352.
59. Zhao Y, Chen L N, Zhang L C, et al. Predicting disease genes of coronary artery disease based on functional consistency and network topological features. Prog Biochem Biophys, 2009, 36: 781-786.
60. Sun H C, Li D, Wang J, et al. PNmerger: a cytoscape plugin to merge biological pathways and protein interaction networks. Prog Biochem Biophys, 2009, 36: 1613-1616.
61. Li F, Bo X C, Li P, et al. Discovering active subnetwork in protein interaction network. Prog Biochem Biophys, 2010, 37: 208-217.
62. Sun R X, Dong M Q, Chi H, et al. ECD/ETD-based tandem mass spectrometry in proteomics. Prog Biochem Biophys, 2010, 37: 94-102.
63. Zhang J, Liu Q M, Xu D K, et al. In situ fabrication and application of protein microarray with cell-free system. Prog Biochem Biophys, 2009, 36: 391-397.
64. Li N, Wu S F, Zhu Y P, et al. The progress of protein quality control methods in shotgun proteomics. Prog Biochem Biophys, 2009, 36: 668-675.
65. Li F, Li M Y, Xiao Z Q, et al. Construction of a nasopharyngeal carcinoma 2D/MS repository with open source XML database - Xindice. BMC Bioinformatics, 2006, 7: 13.
66. Cheng A L, Huang W G, Chen Z C, et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res, 2008, 14: 435-445.
67. Cheng A L, Huang W G, Zhang P F, et al. Comparative proteomics analysis of LCM purified nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue. Prog Biochem Biophys, 2008, 35: 521-530.
68. Feng X P, Yi H, Li M Y, et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res, 2010, 70: 3450-3462.
69. Zeng X, Zhao L, Li Z, et al. Impact of experimental and demographic variables in serum peptide profiling based on magnetic bead and MALDI-TOF mass spectrometry. Clin Chim Acta, 2010, 412: 112-119.
70. Liang K, Chen Z C, Yi H, et al. Screening of EGFR-regulated secreted proteins in human NPC cell line CNE2. Prog Biochem Biophys, 2007, 34: 100-106.
71. Li J, Tan C, Xiang Q, et al. Search for differentially expressed proteins involved in the treatment of human nasopharyngeal carcinoma cells with NGX6 using two-dimensional electrophoresis and mass spectrometry. Prog Biochem Biophys, 2001, 28: 573-578.
72. Li J, Tan C, Xiang Q, et al. Proteomic detection of changes in protein synthesis induced by NGX6 transfected in human nasopharyngeal carcinoma cells. J Protein Chem, 2001, 20: 265-271.
73. Tan C, Li J, Wang J R, et al. Proteomic analysis of differential protein expression in human nasopharyngeal carcinoma cells induced by NAG7 transfection. Proteomics, 2002, 2: 306-312.
74. Tan C, Li J, Xie Y, et al. Preliminary function study of NAG7 using two-dimensional electrophoresis and mass spectrometry. Acta Biochim Et Biophys Sin, 2001, 33: 373-378.
75. Peng C, Li X L, Zhou M, et al. Study of NPC-related gene BRD7 effect on NPC cell line CNE1. Prog Biochem Biophys, 2005, 32: 842-849.
76. Peng C, Liang S P, Tan C, et al. Researching a novel NPC-related candidate suppressor gene BRD7 by two-dimensional gel electrophoresis and MALDI-TOF-MS. Acta Biochim Et Biophys Sin, 2003, 35: 816-822.
77. Liu H Y, Peng S P, Zhou M, et al. Progress of epigenetic study on nasopharyngeal carcinoma. Prog Biochem Biophys, 2007, 34: 673-681.
78. Feng W X, Wang K J, He B, et al. Method to analyze gene promoter methylation inhibition effect on binding of transcription factors. Prog Biochem Biophys, 2011, 38: 177-184.
79. Fan S C, Zhang X G. Progress of bioinformatics study in DNA methylation. Prog Biochem Biophys, 2009, 36: 143-150.
80. Jiang L H, Li Y X, Liu Q. Reconstruction of gene regulatory networks by integrating ChIP-chip, knock out and expression data. Prog Biochem Biophys, 2010, 37: 996-1005.
81. Wang X L, Feng Y P, Zhao J, et al. The expression of p16 is regulated by the reversible histone acetylation. Prog Biochem Biophys, 2010, 37: 600-606.
82. Jiang Z W, Liu X G, Zhou Z J. The regulation of histone modifications. Prog Biochem Biophys, 2009, 36: 1252-1259.
83. Yan L M, Wu J Y, Yu X H, et al. Role of intronic microRNA in the regulation of endothelial nitric oxide synthase expression and the proliferation of endothelial cells. Prog Biochem Biophys, 2010, 37: 747-753.
84. Zhang Z P, Wu M H, Tang H L, et al. Effects of 5-aza-2'-deoxycitydine on proliferation of glioma cell lines and abnormal methylation of LRRC4 gene. Prog Biochem Biophys, 2009, 36: 904-909.
85. Zhang W J, Yi B, Yi H, et al. Identification of hypermethylated genes in nasopharyngeal carcinoma cell line by proteomics. Prog Biochem Biophys, 2008, 35: 410-417.
86. Lo K W, Kwong J, Hui A B, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res, 2001, 61: 3877-3881.
87. Yi M, Yang J, Chen X, et al. RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression. J Cell Physiol, 2011, 226: 2360-2369.
88. Li L L, Tao Q, Jin H C, et al. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clin Cancer Res, 2010, 16: 2949-2958.
89. Tan S X, Hu R C, Dai A G, et al. DNA methylation inhibits ANXA1 gene expression in nasopharyngeal carcinoma cell lines. Prog Biochem Biophys, 2009, 36: 1319-1326.
90. Tan S X, Li J, Yi H, et al. Hypermethylation leads to down-regulated 14-3-3 sigma expression in nasopharyngeal carcinoma tissues. Prog Biochem Biophys, 2009, 36: 743-749.
91. Jin Y F, Xu G M, Li Y, et al. A novel normalization approach for microRNA quantitative PCR. Prog Biochem Biophys, 2011, 38: 473-481.
92. Guo Z Y, Mao C Q, Xiong L L, et al. The high throughput screening of direct regulatory microRNA and their target genes. Prog Biochem Biophys, 2009, 36: 1154-1164.
93. Fu C, Lin K. Computational analysis of miRNA and target mRNA interactions: Combined effects of the quantity and quality of their binding sites. Prog Biochem Biophys, 2009, 36: 608-615.
94. Zhang L M, Deng T, Li X Y, et al. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis, 2010, 31: 559-566.
95. Lu J A, He M L, Wang L, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res, 2011, 71: 225-233.
96. Chen H C, Chen G H, Chen Y H, et al. microRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer, 2009, 100: 1002-1011.
97. Zhao L Q, Chen X, Cao Y. miRNA and nasopharyngeal carcinoma. Chin Sci Bull, 2011, 56: 722-728.
98. Wang X J. The molecular mechanism of herpesvirus membrane fusion. Prog Biochem Biophys, 2010, 37: 583-588.
99. Fan S Q, Ma J, Zhou J, et al. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol, 2006, 37: 593-605.
100. Tang Y L, Lu J H, Cao L, et al. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes. Braz J Med Biol Res, 2008, 41: 110-116.
101. Lin X C, Liu S F, Luo X J, et al. EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells. Int J Cancer, 2009, 124: 1020-1027.
102. Zhang Z W, Zhang Q, Yu Y H, et al. Influence of Epstein-Barr virus encoded latent membrane protein 1-CTAR(3) for proteinic expression and cellular proliferation of NP69 cells. Prog Biochem Biophys, 2009, 36: 580-586.
103. Yu Z Y, Lu J H, Yu H B, et al. A precise excision of the complete Epstein-Barr virus genome in a plasmid based on a bacterial artificial chromosome. J Virol Methods, 2011, doi: 10. 1016/j. jviromet. 2011. 06. 015.
104. Zuo L L, Lu J H, Yu H B, et al. The observation of cell growth in the primary culture of transplantation tumor through GFP readout. Prog Biochem Biophys, 2011, 38: 563-567.
105. Tang Y L, Lu J H, Wu M H, et al. Lytic replication and inductive production of recombinant Epstein Barr virus visualized. Prog Biochem Biophys, 2007, 34: 418-424.
106. Lu J H, Tang Y L, Yu H B, et al. Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance. Lab Invest, 2010, 90: 196-209.
107. Zhou H D, Li G Y, Yang Y X, et al. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol, 2006, 43: 1864-1871.
108. Zhou H D, Li X L, Li G Y, et al. Effect of SPLUNC1 protein on the pseudomonas aeruginosa and Epstein-Barr virus. Mol Cell Biochem, 2008, 309: 191-197.
109. Yang Y X, Yang Y B, Ming Z, et al. The study of nasopharygeal carcinoma cell 5-8F responsiveness to negative Gram's lipopolysaccharide via TLR4-regulating signaling pathway. Prog Biochem Biophys, 2007, 34: 138-145.
110. Yang Y, Zhou H, Li W, et al. Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NFkappaB and MAPKs signaling pathways. Mol Immunol, 2007, 44: 984-992.
111. Zhou H D, Fan S Q, Zhao J, et al. Tissue distribution of the secretory protein, SPLUNC1, in the human fetus. Histochem Cell Biol, 2006, 125: 315-324.
112. Zhou H D, Li X L, Li G Y. PLUNC family: Novel class of innate immune protective molecules in upper airway. Prog Biochem Biophys, 2004, 31: 767-771.
113. Zhu M Y, Fu S G, Li M S, et al. Inhibited the activity of PTEN by alpha-fetoprotein caused resistance to all trans retinoic add of hepatoma cells. Prog Biochem Biophys, 2011, 38: 227-238.
114. Matloob A, Pan L N, Pan H, et al. SMAD-4 cooperates with TGF-beta to enhance PTEN expression upon the inhibition of RAS/ERK pathway in gastric carcinoma cells. Prog Biochem Biophys, 2011, 38: 543-550.
115. Cao D L, Yin K, Mo Z C, et al. Lipopolysaccharide down-regulates ABCA1 expression in foam cells in a nucleus factor-kappa B pathway-dependent manner. Prog Biochem Biophys, 2010, 37: 540-548.
116. Zhang L, Xing D. Molecular mechanism of JNK/Bim/Bax apoptotic pathway induced by TNF-alpha in differentiated PC12 cells. Prog Biochem Biophys, 2010, 37: 370-380.
117. Xue Y, Liu L L, He F, et al. IL-18 stimulates CSF-1 expression via MyD88-dependent pathway. Prog Biochem Biophys, 2011, 38: 311-319.
118. Zhong T Y, Tang J, Chen D Y, et al. Using FRET to study the in teraction domain of TLR4 binding to MD-2 in living cells. Prog Biochem Biophys, 2009, 36: 1451-1457.
119. Sun B, Han D S. Negative regulation of toll-like receptors signaling pathways. Prog Biochem Biophys, 2009, 36: 1516-1522.
120. Zhu X M, Yao Y M, Sheng Z Y. Inflammasome and Inflammatory Response. Inflammasome, 2010, 37: 129-137.
121. Yang Y X, Yang Y B, Li X L, et al. The study of LPLUNC1 gene inhibits human nasopharyngeal carcinoma cell line HNE1 growth and proliferation. Inflammasome, 2007, 34: 366-374.
122. Yu Y, Xie Y, Cao L, et al. Molecular cloning and functional primary study of a novel candidate tumor suppressor gene related with nasopharyngeal carcinoma. Prog Biochem Biophys, 2000, 27: 319-324.
123. Nie X M, Zhang B C, Xiang J J, et al. Construction of prokaryotic expression vector of BRD7 and its expression in E. coli. Prog Biochem Biophys, 2002, 29: 631-634.
124. Zhou J, Ma J, Zhang B C, et al. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. J Cell Physiol, 2004, 200: 89-98.
125. Li S F, Zhou M, Liu H Y, et al. The molecular mechanisms of BRD7 gene in regulating of Rb/E2F pathway. Prog Biochem Biophys, 2007, 34: 881-888.
126. Peng C, Liu H Y, Zhou M, et al. BRD7 suppresses the growth of nasopharyngeal carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways. Mol Cell Biochem, 2007, 303: 141-149.
127. Zhou M, Liu H, Xu X, et al. Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression. J Cell Biochem, 2006, 98: 920-930.
128. Liu H Y, Li G Y. Advances in function analysis of a candidate tumor suppressor gene BRD7 and its family members. Prog Biochem Biophys, 2005, 32: 811-816.
129. Liu H Y, Luo X M, Niu Z X, et al. Cloning and functional characterization of the regulation region of human BRD7 gene. Prog Biochem Biophys, 2006, 33: 531-539.
130. Liu H Y, Zhang L M, Niu Z X, et al. Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells. BMC Cancer, 2008, 8: 253.
131. Deng L, Jing N, Tan G, et al. A common region of allelic loss on chromosome region 3p25.-26. 3 in nasopharyngeal carcinoma. Gene Chromosomes Canc, 1998, 23: 21-25.
132. Tan C, Li J, Wang J R, et al. Effect of NAG7 gene transfection on the growth of nasopharyngeal carcinoma cells. Prog Biochem Biophys, 2002, 29: 372-377.
133. Tan C, Li J, Pen C, et al. The effects of NAG7 on gene expressional profile of HNE1 cells using cDNA microarray analysis. Prog Biochem Biophys, 2003, 30: 99-106.
134. Gao Y, Chen X N, Wei C W, et al. c-abl upregulates the transcriptional activity of ER beta by their interaction. Prog Biochem Biophys, 2010, 37: 74-78.
135. Huang C, Wu M, Tang Y, et al. NAG7 promotes human nasopharyngeal carcinoma invasion through inhibition of estrogen receptor alpha and up-regulation of JNK2/AP-1/MMP1 pathways. J Cell Physiol, 2009, 221: 394-401.
136. Xu S J, Liu G L. Recent progress of mitochondrial dysfunction induced by beta-amyloid protein. Prog Biochem Biophys, 2010, 37: 589-593.
137. Xiang B, Yi M, Wang L, et al. Preparation of polyclonal antibody specific for NOR1 and detection of its expression pattern in human tissues and nasopharyngeal carcinoma. Acta Biochim Et Biophys Sin, 2009, 41: 754-762.
138. Nie X M, Gui R, Li D Q, et al. The effects of NOR1 on cells from human nasopharyngeal carcinoma cell line HNE1. Prog Biochem Biophys, 2005, 32: 777-780.
139. Nie X M, Zhang B C, Li X L, et al. Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol, 2003, 129: 410-414.
140. Li W, Li X, Wang W, et al. NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma. Carcinogenesis, 2011, 32: 1305-1314.
141. Xiang B, Wang L, Yi M, et al. Screen and identification of the protein-protein interactors of NOR1, a novel gene down-regulated in nasopharyngeal carcinoma. Prog Biochem Biophys, 2009, 36: 709-714.
142. Zhou Y H, Zeng Z Y, Zhang W L, et al. Lactotransferrin: A candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer, 2008, 123: 2065-2072.
143. Yi H M, Li H, Peng D, et al. Genetic and epigenetic alterations of LTF at 3p21. 3 in nasopharyngeal carcinoma. Oncol Res, 2006, 16: 261-272.
144. Ma J, Zhou J, Fan S, et al. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis, 2005, 26: 281-291.
145. Lian P, Guo Q, Peng Y, et al. The role of NGX6 gene on apoptosis of human colon cancer. Prog Biochem Biophys, 2008, 35: 1154-1160.
146. Wang X Y, Shen S R, Liu F, et al. Inhibitory effects of NGX6 gene on EGFR/K-ras/JNK/c-Jun/cyclin D1 signal pathway in the colon cancer. Prog Biochem Biophys, 2008, 35: 570-576.
147. Guo Q, Shen S, Liao M, et al. NGX6 inhibits cell invasion and adhesion through suppression of Wnt/beta-catenin signal pathway in colon cancer. Acta Biochim Biophys Sin (Shanghai), 2010, 42: 450-456.
148. Liu M, Peng Y, Wang X, et al. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer. BMC Cancer, 2010, 10: 160.
149. Peng Y, Li H, Wu M, et al. NGX6 inhibits AP-1 and Ets-1 expression and down-regulates cyclin D1 in human colorectal cancer. Acta Biochim Biophys Sin (Shanghai), 2009, 41: 504-514.
150. Guo Q, Wu M, Lian P, et al. Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt/beta-catenin signaling pathway. Mol Cell Biochem, 2009, 330: 71-81.
151. Ma J, Li J, Zhou J, et al. Profiling genes differentially expressed in NGX6 overexpressed nasopharyngeal carcinoma cells by cDNA array. J Cancer Res Clin Oncol, 2002, 128: 683-690.
152. Zhang X M, Wang X Y, Sheng S R, et al. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. World J Gastroenterol, 2003, 9: 1729-1733.
153. Fan S Q, Zhang W L, Xu L N, et al. Investigation of clinical significance and expression of tumor metastasis-related genes in the nasopharyngeal cancer using tissue microarray technique. Prog Biochem Biophys, 2009, 36: 616-623.
154. Fan S Q, Zhang W L, Zhou M, et al. Study of in situ expression of NGX6 gene in the several common types of cancer and its clinical significance. Prog Biochem Biophys, 2008, 35: 1014-1020.
155. Wang L, Xiang B, Yi M, et al. Identification of a new seven-span transmembrane protein: NGX6a is downregulated in nasopharyngeal carcinoma and is associated with tumor metastasis. J Histochem Cytochem, 2010, 58: 41-51.
156. Wang L L, Zhang Q H, Ma J, et al. Role of NGX6 in nasopharyngeal carcinoma with high ability of metastasis cell line 5-8F. Prog Biochem Biophys, 2005, 32: 618-624.
157. Liu M J, Wang X Y, Shen S R, et al. Cloning and identification of promoter of suppressed-tumor gene NGX6. Prog Biochem Biophys, 2010, 37: 1082-1089.
158. Zhang H D, Wang X N, Zhou Z, et al. Mutation detection of K-ras gene in paraffin-embedded colorectal cancer tissues by using chip-based TGCE. Prog Biochem Biophys, 2010, 37: 794-800.
159. Peng S, Fan S, Li X, et al. The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor. Cancer Sci, 2007, 98: 341-349.
160. Peng S P, Li X L, Wang L, et al. The role of NGX6 and its deletion mutants in the proliferation, adhesion and migration of nasopharyngeal carcinoma 5-8F cells. Oncology, 2006, 71: 273-281.
161. Wang L L, Ma J, Li J, et al. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem, 2005, 95: 64-73.
162. Wang X Y, Wu M H, Liu F, et al. Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem, 2011, 345: 283-290.
163. Song L B, Zeng M S, Liao W T, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res, 2006, 66: 6225-6232.
164. Song L B, Li J, Liao W T, et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest, 2009, 119: 3626-3636.
165. Hui A B Y, Or Y Y Y, Takano H, et al. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13. 3 in nasopharyngeal carcinoma. Cancer Res, 2005, 65: 8125-8133.
166. Xiao B, Fan S, Zeng Z, et al. Purification of novel UBAP1 protein and its decreased expression on nasopharyngeal carcinoma tissue microarray. Protein Expr Purif, 2006, 47: 60-67.
167. Qian J, Dong L, Zhang B C, et al. Identification and digitalized expression analysis of murine UBAP1 gene by means of EST database searching. Prog Biochem Biophys, 2002, 29: 323-327.
168. Zeng Z Y, Xiong W, Zhou Y H, et al. Effect of UBAP1 gene transfection on the growth of nasopharyngeal carcinoma cells. Prog Biochem Biophys, 2005, 32: 929-936.
169. Qian J, Yang J, Zhang X, et al. Isolation and characterization of a novel cDNA, UBAP1, derived from the tumor suppressor locus in human chromosome 9p21-22. J Cancer Res Clin Oncol, 2001, 127: 613-618.
170. Li L, He X S, Luo Q A, et al. Effect of STGC3 gene deletion mutant on the growth of CNE2 cells. Prog Biochem Biophys, 2011, 38: 248-253.
171. Qiu Q C, Bo H, He X S, et al. Tumorigenicity investigation of CNE2 cell line STGC3 expression induced by tet-on system in nude mice. Prog Biochem Biophys, 2007, 34: 359-365.
172. Hu B, Qiu Q C, He X S, et al. Effect of estrogen on CNE2 cell line transfected with STGC3 gene. Prog Biochem Biophys, 2007, 34: 538-545.
173. Deng M, He X S, Luo Q, et al. Tet regulating express on system establishment and functional analysis of novel gene STGC3 in nasopharyngeal carcinoma cell line CNE2. Prog Biochem Biophys, 2006, 33: 39-44.
174. Yang S, Hu H, Deng M, et al. Effect of the novel gene NPCEDRG associated with NPC on the growth of CNE2 cells. Prog Biochem Biophys, 2010, 37: 167-174.
175. Yan C, Jun L, Hong Y, et al. RKIP downregulation associated with the metastasis and activation of NF-kappa B signaling pathway in nasopharyngeal carcinoma. Prog Biochem Biophys, 2009, 36: 880-889.
176. Xie S M, Du S S, Fang W Y, et al. Expression of ten ABC transporters in cisplatin-resistant nasopharyngeal carcinoma cell lines. Prog Biochem Biophys, 2009, 36: 458-463.
177. Liu W, Xie H W. Potential drug target discovery based on bioinformatics methods. Prog Biochem Biophys, 2011, 38: 11-19.
178. Yi W Y, Xu B, Li M, et al. Reversal effect of a novel N-sugar substituted thalidomide analogue on multidrug resistant human nasopharyngeal carcinoma cells. Prog Biochem Biophys, 2009, 36: 58-64.
179. Cao C S, Shen W Z, Li Y L, et al. 3, 5-Hydroxy-6, 7, 3′, 4′-tetramethoxyflavone isolated from Laggera pterodonta induces CNE cell apoptosis. Prog Biochem Biophys, 2011, 38: 254-261.
180. Su B, Tang H L, Deng M, et al. Stage-associated dynamic activity profile of transcription factors in nasopharyngeal carcinoma progression based on protein/DNA array analysis. OMICS, 2011, 15: 49-60.
181. Su B, Xiang B, Wang L, et al. Profiling and comparing transcription factors activated in non-metastatic and metastatic nasopharyngeal carcinoma cells. J Cell Biochem, 2010, 109: 173-183.
182. Wu M, Li X, Li G. Signaling transduction network mediated by tumor suppressor/susceptibility genes in NPC. Curr Genomics, 2009, 10: 216-222.